The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing growth due to the rise in the incidence of chronic diseases especially cardiac disease, and increase in focus of the key players toward innovative extracorporeal membrane oxygenation (ECMO) machine technologies which are expected to drive the growth of the market. WILMINGTON, Del. , Aug.
20, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, " Extracorporeal Membrane Oxygenation Machine (ECMO) Market by Type (Veno-arterial, Veno-venous and Others), Components (Pumps, Oxygenator, Controllers and Others), and Application (Adult, Pediatric and Neonates): Global Opportunity Analysis and Industry Forecast, 2024-2033" . According to the report, the extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is estimated to reach $793.
7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033. Request Sample of the Report on Extracorporeal Membrane Oxygenation Machine (ECMO) Market Forecast 2033 - https://www.
alliedmarketresearch.com/request-sample/A284556 Prime determinants of growth The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing growth due to several factors such as an increase in the prevalence of severe respiratory diseases, including pneumonia, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS) . Modern life support systems have become essential due to.